Addressing Questions About COVID-19
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of the disease and the consequences of the pandemic. The Dialogue series is intended for healthcare clinicians and researchers, including infectious disease and HIV specialists. This (more…)
The Elements of Taking a Sexual History
Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HIV disease as part of a nationwide continuing medical education (CME) effort for physicians. Taking a sexual history from patients is a necessary first step towards providing necessary counseling. A sexual history allows clinicians to identify those individuals at (more…)
(Part 2 of 4) Medical Cannabis in People With HIV: What’s the Evidence
Overview Assessment of Needs Medical cannabis is now legal in the majority of US states. Most individuals seeking medical cannabis do so for pain, which is common in people with HIV (PWH), and there has been increasing interest in understanding the role of cannabis in reducing opioid prescribing and treating opioid use disorder. This talk (more…)
PEP to PrEP Transitions: Evidence and Innovations
Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HIV disease as part of a nationwide continuing medical education (CME) effort for physicians. This webinar will focus on strategies for transitioning patients from postexposure prophylaxis (PEP) to preexposure prophylaxis (PrEP) in clinical practice. We will review trends in (more…)
Lessons From the Lab: Implications for Coronavirus Vaccine and Therapeutics Research and Development
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of the disease and the consequences of the pandemic. The Dialogue series is intended for healthcare clinicians and researchers, including infectious disease and HIV specialists. Robert (more…)
State of the Art Strategies for the Use of Antiretroviral Drugs for the Management, Treatment, and Prevention of HIV Infection
Overview Assessment of Needs Guidelines for antiretroviral drugs for treatment and prevention continue to evolve. This webinar will address some of the most recent findings in HIV medicine and research and discuss how to apply them to clinical practice. Learning Objectives On completion of this webinar, learners will be able to: Summarize the new research (more…)
2020 IAS-USA Guidelines: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
If you registered for the course before Wednesday, October 28, an email from IAS-USA Support (a no-reply Zoom address) with your personal link to access the virtual course was sent to you today at 3:00 PM ET. You will also receive a 1-hour reminder today at 11:30 AM ET (8:30 AM PT, 9:30 AM (more…)
(Part 3 of 4) Opioid Use and HIV/Hepatitis C Made Easy: A Practical Implementation of the Evidence
Overview Update: This webinar has been rescheduled to Tuesday, November 10, 2020. Assessment of Needs Opioid use disorder is a growing crisis among people in the US, and people with HIV (PWH) are particularly affected. This talk will summarize the current knowledge in the field (eg, epidemiology, neurobiology) and will present a real-world, stepwise approach (more…)
National IAS–USA Virtual Update Course on HIV Management
If you registered for the course before 8:00AM PT on Wednesday, November 11, an email from Zoom (be sure to add no-reply@zoom.us to your “safe sender” list) with your personal link to access the virtual course was sent to you today, November 11 at 1:00 PM ET. You will also receive a 1-hour reminder on Thursday, (more…)
When the Going Gets Tough, the Tough Keep Going: Impact of the COVID-19 Pandemic on Hepatitis C and STI Testing and Care
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of the disease and the consequences of the pandemic. The Dialogue series is intended for healthcare clinicians and researchers, including infectious disease and HIV specialists. The (more…)